Deutsche Bank, one of Europe’s largest financial institutions, has surged to a 10-year high, signaling renewed investor confidence and validation of CEO Christian Sewing’s turnaround strategy.
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
SharpLink Gaming Stock dropped over 20% after the company announced a $6 billion stock sale to buy Ethereum. This bold move shook the stock market, catching investors off guard with its scale and focus on cryptocurrency. We explore what happened, why it matters, and how it fits into bigger trends. Continue Reading on Meyka This…
Pratt & Whitney has won a $2.8 billion production contract for Lot 18 F135 engines. The engines power all three F-35 variants for U.S. and international buyers. The award is an undefinitized contract action, announced on August 26, 2025. Continue Reading on Meyka This article is available in full on our main platform. Get access…
The FTSE 100 dipped a bit today, but it still held strong at 8772.17, up by 13.18 points. A ceasefire between Iran and Israel after 12 days of US bombing eased some tension, while stars like Babcock International and Halfords stood out. This mix of global calm and company wins keeps investors watching the FTSE…
The Dow Jones Industrial Average fell sharply by 571 points in early Monday trade as rising tensions between the United States and Iran shook global markets. Investors rushed to safe assets, oil prices jumped, and stock futures signaled more volatility ahead. The sudden drop reflects deep concerns about geopolitical risk, inflation pressure, and global economic…
DNB, Norway’s largest financial group, just reported its earnings for the second quarter of 2025, a nd the numbers missed the mark. The bank’s net profit fell by 3% compared to the same quarter last year, signaling a slowdown in growth. While many expected a stronger performance, the actual results showed lower lending activity and…
PHASQ stock trades at $0.000001 on PNK; top‑losers analysis and Meyka AI forecast for PhaseBio Pharmaceuticals